HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tolerability and efficacy of a low-volume enteral supplement containing key nutrients in the critically ill.

AbstractBACKGROUND & AIMS:
To compare early supplementation with antioxidants and glutamine using a low-volume enteral supplement containing key nutrients to an energy adjusted standard elementary diet and to investigate its effect on clinical efficacy and tolerability in critically ill patients with sepsis/SIRS. The primary endpoints were length of stay in the ICU and sufficient enteral feed.
METHODS:
This was a randomized, prospective, single-blind, controlled study in 58 critically ill patients (56.9% male, mean age 46.7 years, mean APACHE II score 21.6). They received either a low-volume enteral supplement containing key nutrients or a diluted standard nutrition solution. After 10 or 14 days inflammatory parameters, catecholamine need, and maximal enteral delivery were determined.
RESULTS:
Patients receiving a low-volume enteral supplement containing key nutrients did not reach sufficient enteral feed more often than controls (76 vs. 62%, respectively, p = 0.17). The difference in vitamin E and selenium uptake was higher in the treatment group than controls (12.4 vs. 3.7 and 54.7 vs. 16.3, respectively, p ≤ 0.011). Parameters such as fever, antibiotic treatment, artificial ventilation, and death were comparable. This was also true for days of ICU or hospital stay (33 ± 23 and 49 ± 34 days, respectively).
CONCLUSIONS:
The low-volume enteral supplement containing key nutrients was well tolerated and led to a better vitamin E and selenium supply. However, it did not affect length of ICU or hospital stay. Further studies are necessary to determine which disease-specific subgroups may benefit from this supplementation or which group may be harmed.
AuthorsAndrea Schneider, Andrea Markowski, Michael Momma, Claudia Seipt, Birgit Luettig, Johannes Hadem, Michaela Wilhelmi, Michael P Manns, Jochen Wedemeyer
JournalClinical nutrition (Edinburgh, Scotland) (Clin Nutr) Vol. 30 Issue 5 Pg. 599-603 (Oct 2011) ISSN: 1532-1983 [Electronic] England
PMID21621886 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2011 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.
Chemical References
  • Antioxidants
  • Glutamine
  • Vitamin E
  • Selenium
Topics
  • Adult
  • Antioxidants (administration & dosage, adverse effects, therapeutic use)
  • Critical Illness
  • Energy Intake
  • Enteral Nutrition (adverse effects)
  • Female
  • Fever (complications, etiology, prevention & control)
  • Food, Formulated (adverse effects, analysis)
  • Glutamine (administration & dosage, adverse effects, therapeutic use)
  • Humans
  • Intensive Care Units
  • Length of Stay
  • Male
  • Middle Aged
  • Pilot Projects
  • Selenium (administration & dosage)
  • Sepsis (complications, physiopathology, therapy)
  • Single-Blind Method
  • Systemic Inflammatory Response Syndrome (complications, physiopathology, therapy)
  • Vitamin E (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: